1. Home
  2. ALLO vs SHBI Comparison

ALLO vs SHBI Comparison

Compare ALLO & SHBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$2.44

Market Cap

539.4M

Sector

Health Care

ML Signal

HOLD

Logo Shore Bancshares Inc

SHBI

Shore Bancshares Inc

HOLD

Current Price

$18.23

Market Cap

601.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLO
SHBI
Founded
2017
1876
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
539.4M
601.1M
IPO Year
2018
1997

Fundamental Metrics

Financial Performance
Metric
ALLO
SHBI
Price
$2.44
$18.23
Analyst Decision
Buy
Buy
Analyst Count
11
3
Target Price
$8.40
$19.17
AVG Volume (30 Days)
4.3M
184.5K
Earning Date
03-12-2026
04-28-2026
Dividend Yield
N/A
2.70%
EPS Growth
34.09
34.85
EPS
N/A
1.78
Revenue
N/A
$20,853,000.00
Revenue This Year
N/A
$9.16
Revenue Next Year
$140,929.80
$6.71
P/E Ratio
N/A
$9.96
Revenue Growth
N/A
N/A
52 Week Low
$0.86
$11.47
52 Week High
$2.80
$20.68

Technical Indicators

Market Signals
Indicator
ALLO
SHBI
Relative Strength Index (RSI) 55.11 48.62
Support Level $2.20 $17.32
Resistance Level $2.76 $19.31
Average True Range (ATR) 0.20 0.50
MACD -0.06 0.00
Stochastic Oscillator 56.06 66.67

Price Performance

Historical Comparison
ALLO
SHBI

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

About SHBI Shore Bancshares Inc

Shore Bancshares Inc is a financial holding company. It offers personalized banking, insurance, and investment services to families and businesses in the Mid-Atlantic region. It operates in one business segment- banking. The company's primary source of revenue is derived from interest earned on commercial, residential mortgage and other loans, and fees charged in connection with lending and other banking services located in Maryland, Delaware and Virginia.

Share on Social Networks: